Cargando…
Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
Patients with liver cirrhosis are susceptible to infections due to various mechanisms, including abnormalities of humoral and cell-mediated immunity and occurrence of bacterial translocation from the intestine. Bacterial infections are common and represent a reason for progression to liver failure a...
Autor principal: | Righi, Elda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189843/ https://www.ncbi.nlm.nih.gov/pubmed/30344417 http://dx.doi.org/10.3748/wjg.v24.i38.4311 |
Ejemplares similares
-
Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada
por: Burak, Kelly W., et al.
Publicado: (2016) -
Liver Transplantation for Colorectal Liver Metastases: Current Management and Future Perspectives
por: Puia-Negulescu, Serban, et al.
Publicado: (2021) -
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
por: Righi, Elda, et al.
Publicado: (2018) -
Liver Regeneration and Cell Transplantation for End-Stage Liver Disease
por: Li, Yan, et al.
Publicado: (2021) -
Liver transplant in primary sclerosing cholangitis: Current trends and future directions
por: Shah, Yash R, et al.
Publicado: (2023)